Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Toxicology and Applied Pharmacology|July 6, 2016
Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatinGiulia Maria Camerino, Michela De Bellis, Elena Conte, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 10, 2009
Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo testsRosa Burdi, Jean-François Rolland, Bodvael Fraysse, et al.
Frontiers in Pharmacology|February 27, 2026
Impaired adenosine pathways in HFpEF: insights into cardiorenal alterations and endothelial responsesMaria Antonietta Riemma, Gennaro Madonna, Elena Mele, et al.
Heart & Lung : the Journal of Critical Care|January 3, 2025
Biomarker profiles that differentiate type-1 and type 2 myocardial infarctionMarco Mele, Francesco Mautone, Ilaria Ragnatela, et al.
European Journal of Medicinal Chemistry|April 4, 2025
CUPID: A free drug discovery platform for the explainable multi-ion channel assessment of cardiotoxicityNicola Gambacorta, Fabrizio Mastrolorito, Maria Vittoria Togo, et al.
European Journal of Pharmacology|July 5, 2024
Effects of sacubitril-valsartan on aging-related cardiac dysfunctionMarialucia Telesca, Antonella De Angelis, Maria Donniacuo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 4, 2017
Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacyRoberta Francesca Capogrosso, Paola Mantuano, Kitipong Uaesoontrachoon, et al.
Pageof 10